Strumento inattivo

Altre lingue POZEN Inc.

Azioni

US73941U1025

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

POZEN : Announces Stockholder Approval of its Transaction with Tribute Pharmaceuticals Canada Inc.	02/02/16
POZEN : And Tribute Announce Plan To Proceed With Merger To Form Aralez Pharmaceuticals	07/12/15
POZEN : and Tribute Announce Plan to Proceed With Merger to Form Aralez Pharmaceuticals	07/12/15
POZEN : Reports Third Quarter 2015 Results	09/11/15
POZEN : and Tribute Announce Effectiveness of Registration Statement on Form S-4	06/11/15
POZEN : to Announce Third Quarter 2015 Results on November 9, 2015	26/10/15
POZEN : to Present at the Ladenburg Thalmann Healthcare Conference	15/09/15
POZEN : Appoints James P. Tursi, M.D. Chief Medical Officer	14/09/15
POZEN : Reports Second Quarter 2015 Results	10/08/15
POZEN : Market Updates on Drug Manufacturers - Other Equities -- Isis Pharma, Endo Intl., Amarin, United Therapeutics, and POZEN	30/07/15
POZEN : Announces August 10th Webcast of Second Quarter 2015 Results	27/07/15
POZEN : Appoints Scott Charles Senior Vice President of Finance	27/07/15
POZEN : Announces Key Leadership Additions	22/06/15
POZEN : Announces Strategic Acquisition of Tribute and Growth Capital Commitment from Leading Healthcare Sponsors	08/06/15
POZEN : Announces Strategic Acquisition of Tribute and Growth Capital Commitment from Leading Healthcare Sponsors	08/06/15
POZEN : Forms an Irish Subsidiary and Enters into an Intangible Property Transfer Arrangement	02/06/15
POZEN : Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO	01/06/15
POZEN : Reports First Quarter 2015 Results	08/05/15
POZEN : Reports First Quarter 2015 Results	08/05/15
POZEN : Announces May 8th Webcast of First Quarter 2015 Results	04/05/15

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue POZEN Inc.

Azioni

US73941U1025

Altre lingue

Filtri